ABOUT CYTIVA
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
PRODUCT VIDEOS
FEATURED PRODUCTS
-
![Elevecta Producer Cell Line]( "ELEVECTA™ Producer Cell Line For Stable, Inducible AAV Production")
ELEVECTA™ producer cell line is a stable line for inducible adeno-associated virus (AAV) production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s genome, and it requires only a single induction step to initiate AAV production.
-
![Sefia™ Platform]( "A Cell Therapy Manufacturing Platform Made To Automate Key Steps")
The Sefia™ cell therapy manufacturing platform is made up of two digitally integrated and functionally closed systems that automate key manufacturing steps.
-
![GettyImages-1339300422 CAR T-Cell Immunotherapy]( "A Platform To Transform Cell Therapy Manufacturing")
Explore this end-to-end cell therapy solution transforming cell therapy manufacturing and helping you deliver what’s next in CAR T manufacturing, from starting sample to final doses.
-
![GettyImages-1319439243-dna-gene-therapy-helix]( "A Comprehensive Upstream Platform For Gene Therapy Applications")
Explore a variety of cell lines, high-performance cell culture media, and single-use bioreactors to suit your process needs for any cell type.
-
![Sefia Select System]( "Comprehensive Solution For Autologous Cell Therapy Manufacturing")
Explore detailed information regarding a comprehensive solution for cell therapy manufacturing that consists of two hardware components, specialized application software, and single-use kits.
-
![GettyImages-1325053945-lab-team-collaboration]( "An Inside Look At Cell Therapy Services And Support")
“Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.
-
![GettyImages-1096502340 lab data]( "Producer Cell Line To Elevate Your AAV Production To The Next Level")
Discover a true producer cell line where Rep, Helper, Cap, and the gene of interest are stably integrated into the host cell's genome, requiring only a single induction step to initiate AAV production.
-
![Lab Plates GettyImages-520238063]( "A Stable Cell Line For Inducible AAV Production")
Delivering on the promise of AAV-based gene therapies beyond rare diseases will require large quantities of high-quality AAV, produced in a robust manner.
-
![Adeno-associated viruses AAV GettyImages-1322096218]( "AAV Manufacturing Workflow")
Explore scalable and flexible single-use solutions from design to delivery that can help you overcome challenges throughout adeno-associated virus (AAV) manufacturing workflow.
WEBINARS AND PODCASTS
APPLICATION NOTES
- How To Successfully Isolate Your T Cells
- Automated Cell Washing And Formulation In CAR T Cell Therapy Manufacturing
- Review Of Applications And Processes In Fixed-Bed Bioreactors
- Lentiviral Vector Production Using Single-Use Bioreactors
- Comprehensive Solution For Autologous Cell Therapy Manufacturing
- Get Full Control Of Your T Cell Isolation
- Exosome Isolation By TFF And Size Exclusion Chromatography
- A Stable Cell Line For Inducible AAV Production
- Using Automated Spinoculation For CAR T Cell Lentiviral Transduction
- Biacore™ SPR Systems For Titer Analysis Of Adeno-Associated Virus
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
![T-cells attacking cancer cells-GettyImages-1318949177]( "End-To-End Manufacturing Of Autologous CAR T Cell Therapies")
Learn about a modular, functionally closed, end-to-end solution for the manufacture of autologous CAR T cell therapies.
-
![Getty Images-823447656-vector-viral-lab-AAV-cell-development]( "Considerations For Developing The Recirculation/Perfusion Process")
Learn about the recirculation and perfusion processes made possible by single-use, fixed-bed bioreactors designed for scaling up adherent cell culture processes.
-
![iStock-597972138-adeno-associated-virus-AAV]( "AAV Manufacturing Workflow")
Discover how to overcome adeno-associated virus (AAV) manufacturing challenges with end-to-end viral vector production solutions from producer cells through filling.
-
![GettyImages-1319439243-dna-gene-therapy-helix]( "Genomic Medicine Demands Manufacturing Innovation")
The promise of novel therapeutic modalities can only be realized when effective science is paired with efficient manufacturing to provide cost-effective therapies to patients in need.
-
![Adeno-associated viruses AAV GettyImages-1322096218]( "A Different Approach To Adeno-Associated-Virus (AAV) Clarification")
Knowledge of the feed stream, process constraints, and goals, makes selecting depth and membrane filter combinations for preliminary bench-scale filterability studies possible.
-
![Laboratory-analysis-GettyImages-1385463753]( "Tips For Viral Vector Production")
Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.
-
![GettyImages-648181930-viral-development-vaccine-lab]( "What Is A Viral Vector?")
Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.
-
![GettyImages-1450698208 Number 3 cut on note paper]( "Three Key Considerations For Optimizing Process Development")
When it comes to process development, timing, technology, and partners all merit careful consideration. Explore expert insights into these three crucial factors.
-
![GettyImages-1172642339-process-plan-planning-quality]( "Navigating Cell Therapy Process Development")
Equip yourself with the knowledge necessary to make well-informed decisions by exploring the main challenges and considerations inherent in cell therapy process development.
-
![GettyImages-1297146235-dna]( "A Scalable Single-Use Two-Step pDNA Purification Process")
Evaluate the performance of a single-use two-step plasmid purification process, and see how it compares to the existing three-step purification method.
NEWS
- Innovation And Automation Are Driving Forces Behind Next Generation Cell Therapy Manufacturing Platform From Cytiva
- Cytiva And Multiply Labs Collaborate To Automate Cell Therapy Manufacturing
- Cytiva And Brooks Life Sciences To Enhance Automation In Cold Chain Solutions
- G-CON Manufacturing And GE Healthcare Announce Collaboration To Advance Early-Stage Cell Therapy And Viral Vector Manufacturing
- Scaling Up Cell Therapy Manufacturing In Guangzhou
- GE Healthcare Life Sciences Opens Cell And Gene Therapy Asia Technology Center In Shanghai